Unicycive Therapeutics
$6.93
69
-$0.19-2.67% Thursday 20:00
Statistics
Day High
7.08
Day Low
6.77
52W High
11
52W Low
3.71
Volume
430,911
Avg. Volume
559,383
Mkt Cap
148.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
0.194883
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-75.65MNet Income
Analyst Ratings
$31.00Average Price Target
The highest estimate is 40.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow UNCY. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Gilead Sciences
GILD
Mkt Cap148.78B
Abbvie
ABBV
Mkt Cap385.18B
AMGEN
AMGN
Mkt Cap160.66B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Novo Nordisk
NVO
Mkt Cap217.54B
Pfizer
PFE
Mkt Cap140.15B
Astrazeneca
AZN
Mkt Cap256.58B
Merck
MRK
Mkt Cap214.76B
About
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Show more...
CEO
Dr. Shalabh K. Gupta M.D., MPA
Employees
22
Country
US
ISIN
US90466Y2028
Listings
0 Comments
Share your thoughts
FAQ
What is Unicycive Therapeutics stock price today?▼
The current price of UNCY is $6.93 USD — it has decreased by -2.67% in the past 24 hours. Watch Unicycive Therapeutics stock price performance more closely on the chart.
What is Unicycive Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Unicycive Therapeutics stocks are traded under the ticker UNCY.
Is Unicycive Therapeutics stock price growing?▼
UNCY stock has risen by +8.45% compared to the previous week, the month change is a +1.46% rise, over the last year Unicycive Therapeutics has showed a +1,243.28% increase.
What is Unicycive Therapeutics market cap?▼
Today Unicycive Therapeutics has the market capitalization of 148.93M
When is the next Unicycive Therapeutics earnings date?▼
Unicycive Therapeutics is going to release the next earnings report on May 19, 2026.
What were Unicycive Therapeutics earnings last quarter?▼
UNCY earnings for the last quarter are -0.82 USD per share, whereas the estimation was -0.46 USD resulting in a -78.26% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Unicycive Therapeutics revenue for the last year?▼
Unicycive Therapeutics revenue for the last year amounts to 0 USD.
What is Unicycive Therapeutics net income for the last year?▼
UNCY net income for the last year is -75.65M USD.
How many employees does Unicycive Therapeutics have?▼
As of April 05, 2026, the company has 22 employees.
In which sector is Unicycive Therapeutics located?▼
Unicycive Therapeutics operates in the Health Care sector.
When did Unicycive Therapeutics complete a stock split?▼
The last stock split for Unicycive Therapeutics was on June 20, 2025 with a ratio of 1:10.
Where is Unicycive Therapeutics headquartered?▼
Unicycive Therapeutics is headquartered in Los Altos, US.